Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial.
Topic:
Lipids (Epidemiology and Prevention)
Speaker:
Professor M. Landray (Oxford, GB)
Event:
ESC Congress 2017
Congress Presentation
Access the full session
About the event
